Annual Total Liabilities
$2.62 M
+$600.10 K+29.76%
30 June 2024
Summary:
InMed Pharmaceuticals annual total liabilities is currently $2.62 million, with the most recent change of +$600.10 thousand (+29.76%) on 30 June 2024. During the last 3 years, it has risen by +$212.10 thousand (+8.82%). INM annual total liabilities is now -29.45% below its all-time high of $3.71 million, reached on 30 June 2022.INM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.07 M
-$547.00 K-20.90%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly total liabilities is currently $2.07 million, with the most recent change of -$547.00 thousand (-20.90%) on 30 September 2024. Over the past year, it has increased by +$730.50 thousand (+54.55%). INM quarterly total liabilities is now -60.32% below its all-time high of $5.22 million, reached on 31 December 2021.INM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.8% | +54.5% |
| 3 y3 years | +8.8% | -1.7% |
| 5 y5 years | +119.8% | +46.4% |
INM Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +29.8% | -60.3% | +54.5% |
| 5 y | 5 years | -29.4% | +119.8% | -60.3% | +54.5% |
| alltime | all time | -29.4% | +5767.0% | -60.3% | >+9999.0% |
InMed Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.07 M(-20.9%) |
| June 2024 | $2.62 M(+29.8%) | $2.62 M(+16.1%) |
| Mar 2024 | - | $2.25 M(-9.2%) |
| Dec 2023 | - | $2.48 M(+85.4%) |
| Sept 2023 | - | $1.34 M(-33.6%) |
| June 2023 | $2.02 M(-45.6%) | $2.02 M(-13.9%) |
| Mar 2023 | - | $2.34 M(-9.4%) |
| Dec 2022 | - | $2.58 M(-27.7%) |
| Sept 2022 | - | $3.58 M(-3.6%) |
| June 2022 | $3.71 M(+54.2%) | $3.71 M(-19.4%) |
| Mar 2022 | - | $4.60 M(-11.8%) |
| Dec 2021 | - | $5.22 M(+147.7%) |
| Sept 2021 | - | $2.11 M(-12.4%) |
| June 2021 | $2.40 M(+25.0%) | $2.40 M(+24.6%) |
| Mar 2021 | - | $1.93 M(-53.6%) |
| Dec 2020 | - | $4.16 M(+97.0%) |
| Sept 2020 | - | $2.11 M(+9.6%) |
| June 2020 | $1.92 M(+61.6%) | $1.92 M(+17.8%) |
| Mar 2020 | - | $1.63 M(+4.4%) |
| Dec 2019 | - | $1.56 M(+10.6%) |
| Sept 2019 | - | $1.41 M(+18.8%) |
| June 2019 | $1.19 M(+67.0%) | $1.19 M(+138.1%) |
| Mar 2019 | - | $500.10 K(+23.8%) |
| Dec 2018 | - | $403.90 K(-11.6%) |
| Sept 2018 | - | $457.00 K(-35.9%) |
| June 2018 | $713.00 K(+150.9%) | $713.00 K(+44.7%) |
| Mar 2018 | - | $492.60 K(+108.9%) |
| Dec 2017 | - | $235.80 K(+54.3%) |
| Sept 2017 | - | $152.80 K(-46.2%) |
| June 2017 | $284.20 K(-37.7%) | $284.20 K(+14.9%) |
| Mar 2017 | - | $247.30 K(+54.6%) |
| Dec 2016 | - | $160.00 K(-49.3%) |
| Sept 2016 | - | $315.50 K(-30.8%) |
| June 2016 | $456.20 K(+629.9%) | $456.20 K(-29.7%) |
| Mar 2016 | - | $649.00 K(+71.4%) |
| Dec 2015 | - | $378.70 K(+95.1%) |
| Sept 2015 | - | $194.10 K(+210.6%) |
| June 2015 | $62.50 K(-10.8%) | $62.50 K(-80.4%) |
| Mar 2015 | - | $318.80 K(-28.8%) |
| Dec 2014 | - | $447.70 K(+85.8%) |
| Sept 2014 | - | $240.90 K(+243.7%) |
| June 2014 | $70.10 K(+42.5%) | $70.10 K(-62.0%) |
| Mar 2014 | - | $184.70 K(+98.4%) |
| Dec 2013 | - | $93.10 K(+60.0%) |
| Sept 2013 | - | $58.20 K(+18.3%) |
| June 2013 | $49.20 K | $49.20 K(+49.5%) |
| Mar 2013 | - | $32.90 K(+35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $24.30 K(-45.6%) |
| Sept 2012 | - | $44.70 K(+0.2%) |
| June 2012 | $44.60 K(-3.5%) | $44.60 K(+216.3%) |
| Mar 2012 | - | $14.10 K(+243.9%) |
| Dec 2011 | - | $4100.00(-91.2%) |
| Sept 2011 | - | $46.80 K(+1.3%) |
| June 2011 | $46.20 K(-96.4%) | $46.20 K(-89.7%) |
| Mar 2011 | - | $448.40 K(-67.4%) |
| Dec 2010 | - | $1.38 M(+3.0%) |
| Sept 2010 | - | $1.34 M(+4.6%) |
| June 2010 | $1.28 M(+21.2%) | $1.28 M(-13.1%) |
| Mar 2010 | - | $1.47 M(+9.4%) |
| Dec 2009 | - | $1.34 M(+9.0%) |
| Sept 2009 | - | $1.23 M(+16.9%) |
| June 2009 | $1.05 M(-30.6%) | $1.05 M(-14.4%) |
| Mar 2009 | - | $1.23 M(-0.1%) |
| Dec 2008 | - | $1.23 M(-15.4%) |
| Sept 2008 | - | $1.46 M(-4.1%) |
| June 2008 | $1.52 M(+12.3%) | $1.52 M(+17.7%) |
| Mar 2008 | - | $1.29 M(-9.6%) |
| Dec 2007 | - | $1.43 M(+24.0%) |
| Sept 2007 | - | $1.15 M(-14.8%) |
| June 2007 | $1.35 M(+19.0%) | $1.35 M(+22.6%) |
| Mar 2007 | - | $1.10 M(-5.0%) |
| Dec 2006 | - | $1.16 M(+52.9%) |
| Sept 2006 | - | $760.10 K(-33.2%) |
| June 2006 | $1.14 M(-31.3%) | $1.14 M(-17.2%) |
| Mar 2006 | - | $1.37 M(-1.3%) |
| Dec 2005 | - | $1.39 M(-20.8%) |
| Sept 2005 | - | $1.76 M(+6.1%) |
| June 2005 | $1.66 M(+111.9%) | $1.66 M(-29.8%) |
| Mar 2005 | - | $2.36 M(-27.0%) |
| Dec 2004 | - | $3.23 M(+299.0%) |
| Sept 2004 | - | $809.40 K(+3.6%) |
| July 2004 | $781.40 K(-15.2%) | $781.40 K(+17.6%) |
| Apr 2004 | - | $664.70 K(-27.8%) |
| Jan 2004 | - | $920.50 K(-17.6%) |
| Oct 2003 | - | $1.12 M(+21.1%) |
| July 2003 | $922.00 K(+1139.2%) | $922.00 K(+1585.6%) |
| Apr 2003 | - | $54.70 K(+6.6%) |
| Jan 2003 | - | $51.30 K(-2.3%) |
| Oct 2002 | - | $52.50 K(-29.4%) |
| July 2002 | $74.40 K(-84.9%) | $74.40 K(+1.2%) |
| Apr 2002 | - | $73.50 K(-57.2%) |
| Jan 2002 | - | $171.90 K(-11.8%) |
| Oct 2001 | - | $195.00 K |
| July 2001 | $493.00 K | - |
FAQ
- What is InMed Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual total liabilities year-on-year change?
- What is InMed Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly total liabilities year-on-year change?
What is InMed Pharmaceuticals annual total liabilities?
The current annual total liabilities of INM is $2.62 M
What is the all time high annual total liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total liabilities is $3.71 M
What is InMed Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, INM annual total liabilities has changed by +$600.10 K (+29.76%)
What is InMed Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of INM is $2.07 M
What is the all time high quarterly total liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total liabilities is $5.22 M
What is InMed Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, INM quarterly total liabilities has changed by +$730.50 K (+54.55%)